Skip to main content
Clinical Trials/NCT04631627
NCT04631627
Unknown
Phase 4

A Prospective Muti-center Study of Early Prediction and Randomised Prevention of Preeclampsia With Low Dose Aspirin in Chinese Cohort

Peking Union Medical College Hospital0 sites1,500 target enrollmentNovember 16, 2020
ConditionsPreeclampsia
InterventionsAspirin

Overview

Phase
Phase 4
Intervention
Aspirin
Conditions
Preeclampsia
Sponsor
Peking Union Medical College Hospital
Enrollment
1500
Primary Endpoint
the rate of preeclampsia
Last Updated
5 years ago

Overview

Brief Summary

This study intends to adopt the method of multi-center prospective randomized controlled study. The aim of this study is to obtain localized excision values through a preeclampsia screening model established in early pregnancy, and to evaluate the efficacy of low-dose aspirin intervention for preeclampsia prevention in pregnant women at high risk of screening.

Registry
clinicaltrials.gov
Start Date
November 16, 2020
End Date
August 30, 2022
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Pregnant women assessed as at high risk of preeclampsia 2) live pregnancy 3) gestational weeks \< 16 weeks 4) agree to randomized drug intervention studies 5) follow up regularly and obtain reliable pregnancy outcomes

Exclusion Criteria

  • with severe fetal or chromosomal abnormalities 2) induced labor or spontaneous abortion due to social factors 3) absolute or relative contraindications to aspirin use (allergy to aspirin or other salicylate, or other ingredients of the drug;Acute gastrointestinal ulcer;Active bleeding;In patients with severe G6PD deficiency, acetylsalicylic acid may induce hemolysis or hemolytic anemia.Aspirin asthma)

Arms & Interventions

aspirin group

aspirin,tablet,100/150mg per day,(BMI\<30 100mg/d,BMI≥30 150mg/d),from pregnancy weeks\<16 to 35 weeks or the day of delivery.

Intervention: Aspirin

control group

with no intervention

Intervention: Aspirin

Outcomes

Primary Outcomes

the rate of preeclampsia

Time Frame: through study completion, an average of 1 year

Hypertensive onset after 20 weeks of gestation is accompanied by proteinuria,or with thrombocytopenia, impaired liver function, renal insufficiency,pulmonary edema,headache without other explanation and so on.

the rate of fetal growth restriction

Time Frame: through study completion, an average of 1 year

The birth weight of the fetus is below two standard deviations of the average weight for the same gestational age or below the 10th percentile of normal weight for the same age

the rate of hypertensive disorder during pregnancy

Time Frame: through study completion, an average of 1 year

gestational hypertension, preeclampsia, chronic hypertension with preeclampsia, eclampsia, HELLP syndrome

the rate of placenta abruption

Time Frame: through study completion, an average of 1 year

After 20 weeks of pregnancy, the placenta in its normal position is completely or partially removed from the uterine wall before delivery of the fetus

the rate of postpartum hemorrhage

Time Frame: within 24 hours after the delivery

Within 24 hours after the delivery of the fetus, the bleeding volume of vaginal delivery ≥500ml, cesarean delivery ≥1000ml

the time and type of delivery

Time Frame: within 24 hours after the delivery

gestational week, vaginal delivery and cesarean section

Secondary Outcomes

  • birth weight of newborn(delivery time)
  • Apgar score for newborns(delivery time)
  • the rate of Neonatal NICU occupancy rate(through study completion, an average of 1 year)

Similar Trials